LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: Data from the Almenara Lupus Cohort

Documento (293.8Kb)
application/pdf
application/pdf
Date
2022Author(s)
Ugarte-Gil, M.F.
Gamboa-Cardenas, R.V.
Reátegui-Sokolova, C.
Pimentel-Quiroz, V.R.
Medina, M.
Elera-Fitzcarrald, C.
Zevallos, F.
Pastor-Asurza, C.A.
Lofland, J.
Zazzetti, F.
Karyekar, C.S.
Alarcón, G.S.
Perich-Campos, R.A.
Metadata
Show full item recordAbstract
Objective To determine if achieving lupus low disease activity state (LLDAS) or remission prevents damage accrual in a primarily Mestizo population. Methods Patients with SLE from a single-centre cohort with at least two visits occurring every 6 months were included. The definitions used were the following: for remission, the 2021 Definition Of Remission In SLE; and for LLDAS, the Asia Pacific Lupus Collaboration. Damage accrual was ascertained with the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). Univariable and three multivariable interval-censored survival regression models were done: (1) remission versus not on remission; (2) LLDAS/remission versus active; and (3) remission and LLDAS (not on remission) versus active. Three similar multivariable models were also examined considering the duration on each state. Possible confounders included in these analyses were gender, age at diagnosis, socioeconomic status, educational level, disease duration, antimalarial use and SDI at baseline. Results Two hundred and eighty-one patients were included. Eighty-three patients (29.5%) showed increased SDI during the follow-up. In the analyses of remission, being on remission predicted a lower probability of damage (HR=0.456; 95% CI 0.256 to 0.826; p=0.010). In the analyses of LLDAS/remission, being on LLDAS/remission predicted a lower damage (HR=0.503; 95% CI 0.260 to 0.975; p=0.042). When both states were considered, remission but not LLDAS (not on remission) predicted a lower probability of damage (HR=0.423; 95% CI 0.212 to 0.846; p=0.015 and HR=0.878; 95% CI 0.369 to 2.087; p=0.768, respectively). When the duration of these states was taken into account, remission, LLDAS/remission and LLDAS not on remission were associated with a lower probability of damage accrual. Conclusions LLDAS and/or remission were associated with a lower probability of damage accrual.
Collections
- Artículos de Investigación [1294]
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2
Related items
Showing items related by title, author, creator and subject.
-
Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
Ugarte-Gil, M.F.; Hanly, J.; Urowitz, M.; Gordon, C.; Bae, S.-C.; Romero-Diaz, J.; Sanchez-Guerrero, J.; Bernatsky, S.; Clarke, A.E.; Wallace, D.J.; Isenberg, D.A.; Rahman, A.; Merrill, J.T.; Fortin, P.R.; Gladman, D.D.; Bruce, I.N.; Petri, M.; Ginzler, E.M.; Dooley, M.A.; Ramsey-Goldman, R.; Manzi, S.; Jönsen, A.; Van Vollenhoven, R.F.; Aranow, C.; MacKay, M.; Ruiz-Irastorza, G.; Lim, S.; Inanc, M.; Kalunian, K.; Jacobsen, Sø.; Peschken, C.; Kamen, D.L.; Askanase, A.; Pons-Estel, B.A.; Alarcón, G.S. (BMJ Publishing Group, 2022)Objective To determine the independent impact of different definitions of remission and low disease activity (LDA) on damage accrual. Methods Patients with ≥2 annual assessments from a longitudinal multinational inception ... -
Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort
Quintana, R.; Pons-Estel, G.J.; Roberts, K.; Sacnún, M.; Serrano, R.; Nieto, R.; Conti, S.; Gervasoni, V.; Catoggio, L.J.; Soriano, E.R.; Scolnik, M.; García, M.A.; Alvarellos, A.; Saurit, V.; Berbotto, G.A.; Sato, E.I.; Costallat, L.T.L.; Neto, E.F.B.; Bonfa, E.; Xavier, R.M.; de Oliveira e Silva Montandon, A.C.; Molina-Restrepo, J.F.; Iglesias-Gamarra, A.; Guibert-Toledano, M.; Reyes-Llerena, G.A.; Massardo, L.; Neira, O.J.; Cardiel, M.H.; Barile-Fabris, L.A.; Amigo, M.-C.; Silveira, L.H.; Torre, I.G.D.L.; Acevedo-Vásquez, E.M.; Ugarte-Gil, M.F.; Alfaro-Lozano, J.L.; Segami, M.I.; Chacón-Díaz, R.; Esteva-Spinetti, M.H.; Gomez-Puerta, J.A.; Alarcón, G.S.; Pons-Estel, B.A. (SAGE Publications, 2020)Objectives: This study aimed to compare the clinical features, damage accrual, and survival of patients with familial and sporadic systemic lupus erythematosus (SLE). Methods: A multi-ethnic, multinational Latin American ... -
Better Health-Related Quality of Life in Systemic Lupus Erythematosus Predicted by Low Disease Activity State/Remission: Data From the Peruvian Almenara Lupus Cohort
Ugarte-Gil, M.F.; Gamboa-Cárdenas, R.V.; Reátegui-Sokolova, C.; Medina-Chinchón, M.; Zevallos, F.; Elera-Fitzcarrald, C.; Pimentel-Quiroz, V.; Cucho-Venegas, J.M.; Rodríguez-Bellido, Z.; Pastor-Asurza, C.A.; Alarcón, G.S.; Perich-Campos, R. (John Wiley and Sons, 2020)Objective: To determine if low disease activity state (LDAS)/remission predicts a better health-related quality of life (HRQoL). Methods: Patients with systemic lupus erythematosus from a single center and having completed ...


